Cargando…
Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
INTRODUCTION: The locoregional recurrence (LRR) rate was reported as high as approximately 20% in stage I-II breast cancer following mastectomy. To investigate the risk factors for LRR in pT1–2N0-1 breast cancer patients treated with mastectomy but not radiation, and to define a subgroup of patients...
Autores principales: | Jwa, Eunjin, Shin, Kyung Hwan, Lim, Hyeon Woo, Jung, So-Youn, Lee, Seeyoun, Kang, Han-Sung, Lee, EunSook, Park, Young Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686923/ https://www.ncbi.nlm.nih.gov/pubmed/26691445 http://dx.doi.org/10.1371/journal.pone.0145463 |
Ejemplares similares
-
The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
por: Cho, Won Kyung, et al.
Publicado: (2019) -
Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment
por: Jwa, Eunjin, et al.
Publicado: (2016) -
Treatment results of breast cancer patients with locoregional recurrence after mastectomy
por: Jeong, Yuri, et al.
Publicado: (2013) -
Risk stratification for prediction of locoregional recurrence in patients with pathologic T1–2N0 breast cancer after mastectomy
por: Wang, Jianyang, et al.
Publicado: (2020) -
Multiple nodal locoregional recurrence of pheochromocytoma
por: Ramírez-Plaza, César Pablo, et al.
Publicado: (2015)